胰岛素和炎症性饮食模式显示出妊娠期糖尿病风险的增强预测潜力
Ping Zu1,2,3,4, Haixia Wang1,2,3,4, Lei Zhang1,2,3,4
1Department of Maternal, Child and Adolescent Health, School of Public Health, Center for Big Data and Population Health of IHM, Anhui Medical University, Hefei 230022, China.
坚持高水平的促炎和高胰岛素饮食会增加妊娠糖尿病 (GDM) 的风险. 结合饮食炎症指数 (EDIP) 和高胰岛素指数 (EDIH),可以比单独采用地中海饮食更好地预测GDM.
科学领域:
- 营养科学 营养科学
- 流行病学 流行病学
- 产科 产科 产科 产科 产科
背景情况:
- 饮食和孕期糖尿病 (GDM) 易感性之间的联系尚未完全理解.
- 预炎性和高胰岛素性饮食模式被怀疑是GDM的贡献者.
研究的目的:
- 为了比较与地中海饮食 (MD) 和胰岛素和促炎饮食模式相关的GDM风险.
- 评估这些饮食模式对GDM发生的预测价值.
主要方法:
- 在中国对8495名孕妇进行前性队列研究.
- 使用食物频率问卷进行饮食评估,以计算实证饮食炎症模式 (EDIP),实证饮食高胰岛素血症指数 (EDIH) 和MD分数.
- 通过口服葡萄糖耐受性测试进行GDM诊断;使用逻辑回归评估风险和通过ROC曲线预测值.
主要成果:
- 更高的超胰岛素 (EDIH 或1.39) 和促炎症 (EDIP 或2.40) 饮食的坚持与增加的GDM风险相关.
- 较少遵守地中海饮食 (MD OR 1.33) 与更高的GDM风险有关.
- 结合EDIP和EDIH显示了GDM的强有力的预测值 (AUC = 0.81).
结论:
- 超胰岛素和促炎性饮食模式是GDM的重要风险因素.
- 与单独遵守MD相比,使用EDIP和EDIH一起提供了更有效的GDM预测和潜在预防方法.
更多相关视频
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Symptoms, Diagnosis, and Complications
Dipeptidyl Peptidase 4 Inhibitors
